The discovery could serve as a starting point for antiviral strategies. A research team at Ruhr University Bochum, Germany, has identified a previously unknown cellular mechanism crucial to the ...
Feel a sniffle coming on? Don't reach for the Lemsip, grab a hand blender and whip up a soup which can help your body fight ...
Why do immune cells that are supposed to eliminate viruses suddenly turn against our own body? There are instances where killer T cells—which are meant to precisely remove virus-infected ...
Zacks Small Cap Research on MSN
NNVC: Getting Set for Phase 2 Trial of NV-387 in MPox…
NNVC READ THE FULL NNVC RESEARCH REPORT Business Update Mpox Trial to Initiate in Late 2025/Early 2026 NanoViricides, Inc. (NYSE:NNVC) is planning to initiate a Phase 2 clinical trial for the ...
Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or ...
In-Vitro Data Confirms Strong Protection Against H1N1 Influenza via Physical Barrier Mechanism Ra’anana, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the ...
TipRanks on MSN
Polyrizon announces in-vitro results for PL-16 Viral Blocker
Polyrizon (PLRZ) announced in-vitro results for its product candidate, the PL-16 Viral Blocker, a proprietary nasal gel formulation, confirming a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results